Aytu BioPharma (NASDAQ:AYTU – Get Free Report) announced its quarterly earnings data on Wednesday. The company reported ($0.28) EPS for the quarter, Zacks reports. Aytu BioPharma had a negative return on equity of 21.89% and a negative net margin of 8.28%.
Aytu BioPharma Trading Down 2.1 %
NASDAQ AYTU traded down $0.03 during trading on Wednesday, hitting $1.39. The stock had a trading volume of 57,227 shares, compared to its average volume of 24,390. The company has a market capitalization of $8.55 million, a PE ratio of -1.13 and a beta of -1.45. The company has a quick ratio of 0.80, a current ratio of 0.99 and a debt-to-equity ratio of 0.35. Aytu BioPharma has a twelve month low of $1.30 and a twelve month high of $3.45. The firm has a 50 day moving average price of $1.62 and a 200 day moving average price of $2.01.
Aytu BioPharma Company Profile
See Also
- Five stocks we like better than Aytu BioPharma
- 3 Small Caps With Big Return Potential
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- How to Plot Fibonacci Price Inflection Levels
- Inflation Persists, But So Do Stock Opportunities: Rally On
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for Aytu BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aytu BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.